RT Partners (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:London

RT Partners is a boutique investment firm focused on UK investing in IP-rich technology.

Average round investment:42.5M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: United Kingdom Nuclera
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to RT Partners

Name Criteria
Hong Kong CR-CP Life Science Fund
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Rick Klausner
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
E Ink
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Data Collective (DCVC)
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Singapore G. K. Goh Holdings
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Hong Kong Happiness Capital
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Obvious Ventures
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Switzerland Schroder Adveq
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Invus
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Singapore Clay Capital
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top